Showing 51 - 60 of 495,016
We compare healthcare spending in public and private Medicare using newly available claims data from Medicare Advantage (MA) insurers. MA insurer revenues are 30 percent higher than their healthcare spending. Healthcare spending is 25 percent lower for MA enrollees than for enrollees in...
Persistent link: https://www.econbiz.de/10012964410
There is continuing controversy about the extent to which publicly insured children are treated differently than privately insured children, and whether differences in treatment matter. We show that on average, hospitals are less likely to admit publicly insured children than privately insured...
Persistent link: https://www.econbiz.de/10012984782
Standard theory suggests that optimal consumer cost-sharing in health insurance increases with the price elasticity of demand, yet publicly-provided drug coverage typically involves uniform cost-sharing across drugs. We investigate how private drug plans set cost-sharing in the context of...
Persistent link: https://www.econbiz.de/10012991674
Persistent link: https://www.econbiz.de/10011613448
Persistent link: https://www.econbiz.de/10012002557
Persistent link: https://www.econbiz.de/10012194257
Persistent link: https://www.econbiz.de/10011898991
We compare healthcare spending in public and private Medicare using newly available claims data from Medicare Advantage (MA) insurers. MA insurer revenues are 30 percent higher than their healthcare spending. Healthcare spending is 25 percent lower for MA enrollees than for enrollees in...
Persistent link: https://www.econbiz.de/10012455591
There is continuing controversy about the extent to which publicly insured children are treated differently than privately insured children, and whether differences in treatment matter. We show that on average, hospitals are less likely to admit publicly insured children than privately insured...
Persistent link: https://www.econbiz.de/10012456137
Standard theory suggests that optimal consumer cost-sharing in health insurance increases with the price elasticity of demand, yet publicly-provided drug coverage typically involves uniform cost-sharing across drugs. We investigate how private drug plans set cost-sharing in the context of...
Persistent link: https://www.econbiz.de/10012456398